Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29,881,634
-
Total 13F shares
-
8,722,358
-
Share change
-
-593
-
Total reported value
-
$127,589,352
-
Put/Call ratio
-
75%
-
Price per share
-
$14.64
-
Number of holders
-
46
-
Value change
-
-$1,309,423
-
Number of buys
-
23
-
Number of sells
-
20
Institutional Holders of Profound Medical Corp. - Common Shares (PROF) as of Q3 2021
As of 30 Sep 2021,
Profound Medical Corp. - Common Shares (PROF) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,722,358 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FIL Ltd, GAGNON SECURITIES LLC, LETKO, BROSSEAU & ASSOCIATES INC, Redmile Group, LLC, Blackcrane Capital, LLC, ROYCE & ASSOCIATES LP, Gagnon Advisors, LLC, AWM Investment Company, Inc., and ROYAL BANK OF CANADA.
This page lists
46
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.